Revenue
2024
2025
Guardian Pharmacy Services, Inc. (GRDN)
Price—Loading quote
Net income
2024
2025
Free cash flow
2024
2025
Total cash / debt
CashTotal debt
2023
2024
2025
Financial statements
| 2025 | 2024 | |
|---|---|---|
| Revenue | $1.45B | $1.23B |
| Gross profit | $292.7M | $244.4M |
| Operating income | $72.7M | −$62.9M |
| EBITDAderived | $95.0M | −$43.1M |
| Net income | $49.2M | −$110.0M |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 20, 2026Form 4 | Morris David KSee Remarks | SellClass A Common Stock | 187.9K | $29.68 | $5.58M | 254.5K |
| Mar 20, 2026Form 4 | Pharmacy Investors, LLCOther | SellClass A Common Stock | 827.6K | $29.68 | $24.56M | 1.04M |
| Mar 20, 2026Form 4 | Burke FredSee Remarks | SellClass A Common Stock | 671.4K | $29.68 | $19.93M | 840.4K |
| Mar 20, 2026Form 4 | Salentine Thomas J JrDirector,TenPercentOwner | SellClass A Common Stock · indirect | 3.57M | $29.68 | $105.98M | 4.47M |
| Mar 20, 2026Form 4 | Bindley Capital Partners I, LLCTenPercentOwner | SellClass A Common Stock | 3.57M | $29.68 | $105.98M | 4.47M |